Richard O Williams Selected Research

Pharmaceutical Preparations

11/2021	Pharmacological modulation of T cell immunity results in long-term remission of autoimmune arthritis.
9/2021	Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity.
10/2015	Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development.
10/2010	Nimesulide improves the disease modifying anti-rheumatic profile of methotrexate in mice with collagen-induced arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard O Williams Research Topics

Disease

33	Rheumatoid Arthritis 01/2022 - 01/2004
28	Experimental Arthritis 01/2022 - 01/2002
27	Arthritis (Polyarthritis) 01/2022 - 03/2003
18	Inflammation (Inflammations) 09/2021 - 12/2004
7	Necrosis 08/2011 - 12/2004
6	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2005
5	Pain (Aches) 09/2021 - 10/2008
4	Osteoarthritis 01/2022 - 10/2008
4	Disease Progression 01/2019 - 01/2014
2	Ankylosing Spondylitis 01/2021 - 08/2007
2	Synovitis 12/2016 - 01/2007
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2015 - 08/2007
2	Multiple Sclerosis 09/2012 - 10/2008
1	Autoimmune Diseases of the Nervous System 01/2022
1	Neoplasms (Cancer) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Immune System Diseases (Immune Disorders) 01/2022
1	Carcinogenesis 01/2022
1	Obesity 09/2021
1	Myocarditis (Carditis) 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Cerebral Malaria 01/2020
1	Trypanosomiasis 01/2020
1	Huntington Disease (Huntington's Disease) 01/2020
1	Osteoporosis 01/2020
1	Asthma (Bronchial Asthma) 01/2019
1	Stroke (Strokes) 01/2019
1	Infections 01/2018
1	Atherosclerosis 10/2015
1	Atherosclerotic Plaque (Atheroma) 10/2015

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 01/2022 - 03/2003
13	Collagen Type II (Type II Collagen)IBA 01/2019 - 03/2003
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2016 - 12/2004
5	KynurenineIBA 01/2022 - 05/2009
5	Interleukin-17 (Interleukin 17)IBA 01/2019 - 10/2008
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2008
4	Pharmaceutical PreparationsIBA 11/2021 - 10/2010
4	anthranilic acid (anthranilate)IBA 01/2020 - 01/2013
4	Etanercept (Enbrel)FDA Link 02/2016 - 01/2007
3	CollagenIBA 01/2022 - 08/2010
3	EnzymesIBA 01/2022 - 01/2013
3	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2007
3	ChemokinesIBA 01/2019 - 10/2015
3	Tryptophan (L-Tryptophan)FDA Link 10/2015 - 05/2009
3	Monoclonal AntibodiesIBA 01/2010 - 04/2008
2	AntigensIBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 08/2010
2	AcidsIBA 01/2020 - 01/2020
2	Phosphodiesterase 4 InhibitorsIBA 01/2019 - 01/2010
2	Biological ProductsIBA 10/2017 - 04/2008
2	Therapeutic UsesIBA 01/2016 - 01/2002
2	Methotrexate (Mexate)FDA LinkGeneric 05/2015 - 10/2010
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2014 - 08/2011
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 09/2014 - 05/2009
2	Peroxidase (Myeloperoxidase)IBA 01/2014 - 08/2011
2	nimesulide (Aulin)IBA 01/2014 - 10/2010
2	Antisense OligonucleotidesIBA 04/2009 - 10/2008
1	carfilzomibIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	VaccinesIBA 01/2022
1	SubtilisinIBA 01/2022
1	Virulence Factors (Pathogenicity Factors)IBA 01/2022
1	invariant chain (Ii-Key)IBA 01/2022
1	Serine Proteases (Serine Protease)IBA 01/2022
1	EmulsionsIBA 01/2022
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2022
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2022
1	Staphylococcal Protein A (Protein A)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 11/2021
1	Decitabine FDA Link 11/2021
1	Calcium Gluconate (CBG)IBA 09/2021
1	interleukin 20 (IL-20)IBA 01/2021
1	idelalisibIBA 01/2021
1	ibrutinibIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	SteroidsIBA 01/2020
1	Type II Tumor Necrosis Factor ReceptorsIBA 10/2019
1	ibudilastIBA 01/2019
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2019
1	Immunoglobulin Fc FragmentsIBA 01/2018
1	rho GTPase-activating proteinIBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2017
1	DX-2400IBA 02/2016
1	Peptide Hydrolases (Proteases)FDA Link 02/2016
1	Matrix Metalloproteinases (MMPs)IBA 02/2016
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 02/2016
1	N- alpha- benzoyl- N5- (2- chloro- 1- iminoethyl)- L- ornithine amideIBA 01/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016
1	Interleukin-4 (Interleukin 4)IBA 01/2016
1	arginine deiminaseIBA 01/2016
1	Apolipoproteins E (ApoE)IBA 10/2015
1	LipidsIBA 10/2015
1	N-(3',4'-dimethoxycinnamonyl)anthranilic acidIBA 10/2015
1	AntibodiesIBA 01/2015

Therapy/Procedure

22	Therapeutics 01/2022 - 02/2004
2	Analgesia 08/2015 - 01/2014
1	Aftercare (After-Treatment) 01/2019